Cynata Therapeutics Ltd

CYP

Company Profile

  • Business description

    Cynata Therapeutics Ltd is an Australian stem cell and regenerative medicine company pioneering a revolutionary approach to cell therapy with its proprietary Cymerus platform technology. The company operates in one business segment, namely the development and commercialisation of therapeutic products.

  • Contact

    100 Cubitt Street
    Level 3
    CremorneVIC3121
    AUS

    T: +61 370676940

    https://www.cynata.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

    2

Stocks News & Analysis

stocks

Overvalued ASX share has overly ambitious profit target

We think the new profit target is aggressive and unlikely to be met.
stocks

7 undervalued US stocks that crushed earnings

Arista and GE Vernova remain among the cheapest Morningstar-covered stocks after strong earnings beats.
stocks

Undervalued ASX share hitting on all cylinders

Strong performance across all segments in latest earnings release.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,997.30168.10-1.83%
CAC 408,216.78135.22-1.62%
DAX 4026,045.37553.27-2.08%
Dow JONES (US)50,905.62702.55-1.36%
FTSE 10010,689.87191.68-1.76%
HKSE23,508.17245.67-1.03%
NASDAQ24,282.35227.40-0.93%
Nikkei 22558,860.43801.59-1.34%
NZX 50 Index14,306.963.190.02%
S&P 5007,342.5474.05-1.00%
S&P/ASX 2008,883.20161.50-1.79%
SSE Composite Index3,584.5817.99-0.50%

Market Movers